Immunotherapy Summary for Cytokine Storm in COVID-19
COVID-19 pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has ravaged the world, resulting in an alarming number of infections and deaths, and the number continues to increase. The pathogenesis caused by the novel coronavirus was found to be a disruption of the pro-in...
Saved in:
Main Authors: | Yaqun Li (Author), Wenjie Zhao (Author), Jinhua Liu (Author), Zichao Chen (Author), Qingtao Lv (Author), Zhen Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
by: Jinhua Liu, et al.
Published: (2021) -
Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
by: Wenjie Zhao, et al.
Published: (2021) -
The Management of Cytokine Storm in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2020) -
Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
by: Angela E. Peter, et al.
Published: (2021) -
The therapeutic potential of gelsolin in attenuating cytokine storm, ARDS, and ALI in severe COVID-19
by: Juan Zhi, et al.
Published: (2024)